BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Singh AK, Singh R. Renin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades! World J Diabetes 2022; 13(7): 471-481 [PMID: 36051422 DOI: 10.4239/wjd.v13.i7.471]
URL: https://www.wjgnet.com/1948-9358/full/v13/i7/471.htm
Number Citing Articles
1
Alberto Ortiz, Roberto Alcázar Arroyo, Pedro Pablo Casado Escribano, Beatriz Fernández-Fernández, Francisco Martínez Debén, Juan Diego Mediavilla, Alfredo Michan-Doña, Maria Jose Soler, Jose Luis Gorriz. Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenoneExpert Review of Clinical Pharmacology 2023; 16(6): 519 doi: 10.1080/17512433.2023.2213888
2
Chengren Xu, Xiaowen Ha, Shufen Yang, Xuefei Tian, Hong Jiang. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanismsFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1232790
3
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, Anoop Misra. Finerenone in diabetic kidney disease: A systematic review and critical appraisalDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2022; 16(10): 102638 doi: 10.1016/j.dsx.2022.102638